Reata Pharmaceuticals (RETA) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free RETA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLevi & Korsinsky, LLP Notifies Shareholders of Reata Pharmaceuticals, Inc. (RETA) an Upcoming Claims Deadline in a Class Action Settlementmarkets.businessinsider.com - January 25 at 7:41 PMUpward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024msn.com - December 29 at 8:36 AMBiogen cuts annual profit forecast on higher deal costs (Nov 8)investing.com - November 14 at 8:10 PMBiogen lowers full-year earnings guidance, 3Q revenue beats expectationsproactiveinvestors.com - November 8 at 2:46 PMBiogen cuts annual profit forecast as higher costs persistinvesting.com - November 8 at 9:46 AMBraun Stacey Associates Inc. Lowers Stake in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - October 13 at 11:58 AMReata Pharmaceuticals, Inc. (NASDAQ:RETA) Given Consensus Recommendation of "Hold" by Brokeragesmarketbeat.com - October 13 at 5:17 AMTop Growth Stocks for October 2023msn.com - October 1 at 2:01 PMBiogen Inc.: Biogen Completes Acquisition of Reata Pharmaceuticalsfinanznachrichten.de - September 26 at 10:18 AMBiogen Completes Acquisition of Reata Pharmaceuticalsfinance.yahoo.com - September 26 at 10:18 AMmarketbeat.com - September 26 at 6:04 AMReata Pharmaceuticals, Inc. (NASDAQ:RETA) Is Expected To Breakeven In The Near Futurefinance.yahoo.com - September 13 at 4:32 PMFirst Light Asset Management LLC Sells 475,525 Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - September 12 at 11:44 AMDoes Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?finance.yahoo.com - September 9 at 9:13 AMHighTower Advisors LLC Decreases Position in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - September 7 at 5:31 AMCredit Suisse AG Purchases 2,334 Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - September 1 at 4:55 AMSwiss National Bank Reduces Stake in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - August 31 at 4:48 AM3,204 Shares in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Purchased by Pictet Asset Management SAmarketbeat.com - August 30 at 5:00 AMREATA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale ...businesswire.com - August 28 at 9:14 PMReata Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:RETA)marketbeat.com - August 25 at 6:37 PMReata Pharmaceuticals, Inc. (NASDAQ:RETA) Receives Consensus Recommendation of "Hold" from Analystsmarketbeat.com - August 24 at 5:17 AMUS Bancorp DE Purchases 8,947 Shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - August 23 at 5:00 AMStockNews.com Initiates Coverage on Reata Pharmaceuticals (NASDAQ:RETA)marketbeat.com - August 23 at 1:48 AMReata Pharmaceuticals, Inc. (NASDAQ:RETA) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbankmarketbeat.com - August 20 at 4:27 AMCantor Fitzgerald Reiterates Reata Pharmaceuticals Inc - (RETA) Neutral Recommendationmsn.com - August 15 at 5:38 PMCantor Fitzgerald Reiterates "Neutral" Rating for Reata Pharmaceuticals (NASDAQ:RETA)marketbeat.com - August 15 at 10:59 AMBiondo Investment Advisors LLC Takes $323,000 Position in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - August 11 at 7:54 PMReata Pharmaceuticals Unusual Options Activity For August 11benzinga.com - August 11 at 4:09 PMReata Pharmaceuticals (RETA) Gets a Hold from Barclaysmarkets.businessinsider.com - August 9 at 4:46 AMReata Pharmaceuticals (NASDAQ:RETA) Earns Sell Rating from Analysts at StockNews.commarketbeat.com - August 8 at 1:06 AMEquities Analysts Issue Forecasts for Reata Pharmaceuticals, Inc.'s Q2 2025 Earnings (NASDAQ:RETA)marketbeat.com - August 4 at 11:46 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RETA, EQRX, RVMDmarkets.businessinsider.com - August 2 at 1:42 PMReata Pharmaceuticals Inc - (RETA) Price Target Increased by 53.21% to 175.90msn.com - August 2 at 1:42 PMIntegrated Wealth Concepts LLC Purchases Shares of 11,294 Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - August 1 at 8:42 AMCitigroup Downgrades Reata Pharmaceuticals (NASDAQ:RETA) to Neutralmarketbeat.com - August 1 at 8:16 AMBiogen's Bold $7.3B Acquisition Of Reata: Analyzing The Impact On Investorsmsn.com - July 29 at 12:32 PMReata Pharmaceuticals (NASDAQ:RETA) Stock Rating Lowered by SVB Securitiesmarketbeat.com - July 28 at 6:50 PMBiogen agrees to acquire neurological disease specialist Reata Pharmaceuticals at 60% premiuminvesting.com - July 28 at 11:29 AMRETA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Reata Pharmaceuticals, Inc. Is Fair to Shareholderstechnews.tmcnet.com - July 28 at 11:29 AMBiogen to Acquire Reata Pharmaceuticalsfinance.yahoo.com - July 28 at 11:29 AMReata Pharmaceuticals Shares Soar on Takeover by Biogen >RETAmarketwatch.com - July 28 at 11:29 AMWhy Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?markets.businessinsider.com - July 28 at 11:29 AMmarketbeat.com - July 28 at 6:58 AMExpert Ratings for Reata Pharmaceuticalsmarkets.businessinsider.com - July 24 at 3:12 PM5,396 Shares in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Bought by Raymond James Financial Services Advisors Inc.marketbeat.com - July 20 at 4:21 AMReata Pharmaceuticals, Inc. (NASDAQ:RETA) Shares Sold by DekaBank Deutsche Girozentralemarketbeat.com - July 16 at 4:35 AMMoody Aldrich Partners LLC Invests $4.50 Million in Reata Pharmaceuticals, Inc. (NASDAQ:RETA)marketbeat.com - July 14 at 11:49 AMTD Cowen starts Reata at outperform, cites sales potential of ataxia drugmsn.com - July 6 at 3:53 PMReata Pharmaceuticals, Inc. (NASDAQ:RETA) Given Average Rating of "Moderate Buy" by Brokeragesmarketbeat.com - July 5 at 4:49 AM888 Reaffirms Reiterates Rating for Reata Pharmaceuticals (NASDAQ:RETA)marketbeat.com - June 30 at 3:24 PM Get Reata Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RETA and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report RETA Media Mentions By Week RETA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RETA News Sentiment▼0.000.33▲Average Medical News Sentiment RETA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RETA Articles This Week▼02▲RETA Articles Average Week Get Reata Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RETA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ELAN News Today CYTK News Today ITCI News Today JAZZ News Today IONS News Today BPMC News Today CERE News Today APLS News Today LEGN News Today ASND News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RETA) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
